Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | RHEB | Q15382 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PNMT | P11086 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194684 | 0.82 | ALDH1A1 (0.44) | ALDH1A1TSHRTDP1SMN1; SMN2SLC6A2 | |
| SCHEMBL29960351 | 0.82 | ALDH1A1 (0.44) | ALDH1A1TSHRTDP1SMN1; SMN2SLC6A2 | |
| SCHEMBL2095443 | 0.78 | ALDH1A1 (0.43) | ALDH1A1RHEBTSHRCYP1A2TDP1 | |
| SCHEMBL1547749 | 0.78 | ALDH1A1 (0.40) | ALDH1A1RHEBTSHRCYP1A2TDP1 | |
| SCHEMBL315903 | 0.75 | ALDH1A1 (0.43) | ALDH1A1RHEBTSHRCYP1A2TDP1 | |
| SCHEMBL6325195 | 0.74 | RHEB (0.60) | ALDH1A1RHEBTSHRCYP1A2TDP1 | |
| SCHEMBL11766505 | 0.74 | PNMT (0.48) | ALDH1A1RHEBTSHRCYP1A2TDP1 | |
| SCHEMBL11179875 | 0.74 | HTR2C (0.47) | ALDH1A1TSHRCYP1A2TDP1CYP3A4 | |
| SCHEMBL10370306 | 0.74 | ALDH1A1 (0.40) | ALDH1A1RHEBTSHRCYP1A2TDP1 | |
| SCHEMBL29592755 | 0.73 | ADRA2B (0.43) | ALDH1A1TSHRTDP1TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| CN-113316744-B | Oxime ester photoinitiators with special aroyl chromophores | 巴斯夫欧洲公司 | 2024-07-30 | — | — | CN | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| EP-1778636-A1 | OXIME ESTER PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2007-05-02 | — | — | EP | disclosed |
| US-20060241259-A1 | Oxime ester photoinitiators with heteroaromatic groups | CIBA CORPORATION | 2006-10-26 | — | — | US | disclosed |
| WO-2006037728-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006024617-A1 | COMPOSITIONS CONTAINING ANTHRAQUINONE DYES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006024619-A1 | COMPOSITIONS CONTAINING PHTHALOCYANINE DYES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006024618-A1 | CYANOPYRIDINE-BASED AZO DYES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006018405-A1 | OXIME ESTER PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-02-23 | — | — | WO | disclosed |
| CN-1720245-A | Oxime ester photoinitiators with heteroaryl groups | CIBA SC HOLDING AG (CH) | 2006-01-11 | — | — | CN | disclosed |
| EP-1567518-A2 | OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS | Ciba SC Holding AG (CH) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004050653-A2 | OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | ALDH1A1 823/4885RHEB 4097/4885TSHR 528/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | ALDH1A1 823/4885RHEB 4097/4885TSHR 528/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | ALDH1A1 964/4885RHEB 3164/4885TSHR 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.